HCW Biologics Inc.
HCWBHealthcare|Biotechnology|US
$1.02
-0.02 (-1.92%)
Tangible Book / Share
$21.25
Cash / Share
$2.12
Clinical Trials (2)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT07049328 HCW9302 (Interleukin-2 Fusion Protein) for Alopecia Areata | Alopecia Areata(AA) | P1 | Recruiting | 30 | Open-label | HCW9302, an IL-2 fusion protein |
| NCT05145569 Antitumor Activity of Neoadjuvant Chemotherapy with or Without HCW9218 in Metastatic Advanced Stage Ovarian Cancer | Ovarian Cancer | P2 | Withdrawn | — | RCT, Open-label | Carboplatin AUC 5 and paclitaxel, HCW9218 |